Lv11
48 积分 2022-01-25 加入
Management of nausea and vomiting (N/V) following first-line (1L) zolbetuximab + chemotherapy treatment in claudin-18.2 (CLDN18.2)+, HER2−, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Analysis from the phase 3 SPOTLIGHT and GLOW studies
4天前
已完结
Dual-payload ADCs move into first oncology clinical trials
1个月前
已完结
Pancreatic cancer
2个月前
已完结
Pancreatic cancer
2个月前
已完结
Pancreatic cancer
2个月前
已完结
Current State and Future Directions of Radiation Therapy for Pancreas Adenocarcinoma
5个月前
已关闭
Stereotactic body radiotherapy in pancreatic adenocarcinoma
5个月前
已完结
Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma
5个月前
已完结
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial
5个月前
已完结
Understanding the activity of antibody–drug conjugates in primary and secondary brain tumours
6个月前
已完结
皖公网安备34019202002308
